The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

A specialized model used by researchers is becoming a valuable tool for studying human brain development, diseases and ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...